As of Oct 2, 2026 close
- Market cap
- $5.13M
- P/E (TTM)
- —
- Forward P/E
- —
- Dividend yield
- —
- 52-week range
- $0.49$10.60
- Volume (live)
- —
- Avg. volume (3M)
- 1.11M
Basel Medical Group (BMGL) Stock Price & Financial Analysis
Basel Medical Group Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.95 - $3.35 |
|---|---|
| 52-Week High | $10.60 |
| 52-Week Low | $0.49 |
| Open | $3.05 |
| Volume (last close) | 25.03K |
| Average Volume (3M) | 1.11M |
| Market Cap | 5.13M |
|---|---|
| Shares Outstanding | 1.57M |
| Price to Sales (P/S) | 0.58 |
| Price to Book (P/B) | 1.01 |
| EV/EBITDA | -1.17 |
| Revenue (TTM) | 8.83M |
|---|---|
| Net Income (TTM) | -8.29M |
| Free Cash Flow (TTM) | -11.65M |
| EPS (TTM) | $-5.30 |
| Profit Margin | -93.96% |
| Operating Margin | -19.22% |
| Return on Equity (ROE) | -163.01% |
| Debt to Equity | 0.93 |
| 50-Day MA | $4.92 |
|---|---|
| 200-Day MA | $4.45 |
| 52-Week Change | +100.00% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Basel Medical Group at a Glance
Basel Medical Group (BMGL) has a market capitalization of $5.13M. The stock trades at 0.6× sales. Over the trailing twelve months it lost $8.29M on revenue of $8.83M and burned $11.65M of free cash flow. Revenue grew 12.6% year over year.
It holds $1.05M in cash and securities against $4.71M of debt, a net debt position of $3.66M.
Basel Medical Group does not currently pay a dividend.
The share price is up 103.7% over the past year. At $3.28 it sits within its 52-week range of $0.49 to $10.60, below its 200-day moving average of $4.45.
Frequently Asked Questions About Basel Medical Group
What is the current stock price for BMGL?
As of the Oct 2, 2026 close, BMGL stock trades at $3.28. The 52-week range is $0.49–$10.60, with a day range of $2.95–$3.35.
What is the P/E ratio for BMGL?
The P/E ratio (Price-to-Earnings) for BMGL is shown in the Key Statistics section. This valuation metric helps compare Basel Medical Group Ltd to industry peers.
Does BMGL pay dividends?
Basel Medical Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BMGL?
Analyst ratings and recommendations for BMGL are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of BMGL?
Basel Medical Group's market capitalization is $5.1M, classifying it as a micro-cap company. Basel Medical Group operates in the Healthcare sector within the Medical Care Facilities industry.